Ingredient or product comparison
GHK-Cu Glutathione for Anti-Aging Research: Pathway Comparison
Primary Action Stimulates collagen/elastin synthesis via lysyl oxidase activation; modulates 4,000+ genes toward youthful expression profiles Neutralizes ROS (superoxide, H2O2, hydroxyl radicals); maintains GSH:GSSG ratio >100:1 for redox homeostasis GHK-Cu dr
This source-based comparison does not add ratings or recommend a winner.
- Primary Action
- Stimulates collagen/elastin synthesis via lysyl oxidase activation; modulates 4,000+ genes toward youthful expression profiles
- Neutralizes ROS (superoxide, H2O2, hydroxyl radicals); maintains GSH:GSSG ratio >100:1 for redox homeostasis
- GHK-Cu drives structural repair; GSH protects that repair from oxidative degradation
- Complementary pathways. One builds, one defends
- Molecular Target
- Copper-dependent enzymes (lysyl oxidase, SOD1); TGF-beta signaling; MMP downregulation
- ROS species; oxidized proteins/lipids via glutathione peroxidase and transferase enzymes
- Reduced oxidative stress allows higher fidelity collagen cross-linking and gene expression changes
- GHK-Cu's benefits amplify in low-ROS environments
- Bioavailability Challenge
- High transdermal and subcutaneous absorption; oral bioavailability limited by gastric pH degradation
- Oral GSH degraded by intestinal peptidases; liposomal or NAC precursor forms improve uptake
- Combined transdermal/liposomal delivery bypasses GI breakdown for both compounds
- Delivery method determines efficacy more than dose
- Effective Concentration Range
- 0.5–10 μM in vitro; 1–3 μM optimal for collagen stimulation
- Intracellular: 1–10 mM (physiologic); supplementation raises levels 20–40% depending on baseline depletion
- Low-dose GHK-Cu + baseline GSH restoration produces disproportionate anti-aging markers vs either alone
- Synergy threshold appears at physiologic GSH restoration
- Evidence Base for Anti-Aging
- Gene array studies (Linus Pauling Institute); wound healing trials; extracellular matrix remodeling data
- Longitudinal aging cohorts; mitochondrial function studies; oxidative stress biomarker research
- Limited direct co-administration trials; mechanistic rationale stronger than clinical data
- Mechanistic synergy is clear; human longevity data still emerging